BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31794352)

  • 1. Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab.
    Abe K; Ishikawa Y; Ishikawa J; Fujiwara M; Kita Y
    Immunol Med; 2019 Dec; 42(4):185-188. PubMed ID: 31794352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose rituximab therapy in steroid-refractory thrombocytopenia due to systemic lupus erythematosus.
    Ilizaliturri-Guerra O; Uriarte-Botello R; Pineda-Sic RÁ; Serna-Peña G; Garza-Elizondo MA; Galarza-Delgado DÁ; Leal-Bramasco AS; Elizondo-Solís CV; Santoyo-Fexas L; Villarreal-Alarcón MÁ
    Rheumatol Int; 2020 Oct; 40(10):1717-1724. PubMed ID: 32797277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
    Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
    Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment with belimumab for immune thrombocytopenia associated with systemic lupus erythematosus: A report of two cases.
    Nakayama K; Tamimoto Y; Nakayama T
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):69-73. PubMed ID: 37718578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus].
    Lehembre S; Macario-Barrel A; Musette P; Carvalho P; Joly P
    Ann Dermatol Venereol; 2006 Jan; 133(1):53-5. PubMed ID: 16495854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab therapy for refractory thrombotic thrombocytopenic purpura and autoimmune-mediated thrombocytopenia in systemic lupus erythematosus.
    Hundae A; Peskoe S; Grimsley E; Patel S
    South Med J; 2008 Sep; 101(9):943-4. PubMed ID: 18708978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eltrombopag as steroid sparing therapy for immune thrombocytopenic purpura in systemic lupus erythematosus.
    Maroun MC; Ososki R; Andersen JC; Dhar JP
    Lupus; 2015 Jun; 24(7):746-50. PubMed ID: 25416695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience.
    Zhang C; Liu HF; Chen XH; Gao L; Gao L; Liu Y; Kong PY; Sun AH; Zhang X
    Clin Ther; 2014 Mar; 36(3):385-8. PubMed ID: 24594069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature.
    Jovancevic B; Lindholm C; Pullerits R
    Lupus; 2013 Jun; 22(7):664-74. PubMed ID: 23612795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab use in pediatric autoimmune diseases: four case reports.
    Polido-Pereira J; Ferreira D; Rodrigues AM; Nascimento C; Costa P; Almeida M; da Silva JE; Simão C; Stone R; Ramos F; Neto A; da Costa JC; Melo-Gomes J; Gomes-Pedro J; Viana-Queiroz M; Canhão H; Fonseca JE
    Ann N Y Acad Sci; 2009 Sep; 1173():712-20. PubMed ID: 19758220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Idiopathic thrombocytopenic purpura as first manifestation of systemic lupus erythematosus lupus].
    Balsalobre Aznar J; Herráez Herrera P; Porta Etessam J; Torres Martín C; Bermell Serrano JC; Núñez López R; Mateo Bernardo I; Padrino Martínez JM; Morillas López L
    An Med Interna; 1999 Dec; 16(12):611-4. PubMed ID: 10686711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombocytopenic purpura as initial manifestation of systemic lupus erythematosus.
    Mestanza-Peralta M; Ariza-Ariza R; Cardiel MH; Alcocer-Varela J
    J Rheumatol; 1997 May; 24(5):867-70. PubMed ID: 9150074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic thrombocytopenic purpura that developed 3 years after systemic lupus erythematosus had remitted with rituximab therapy.
    Tsuda R; Kido T; Okada I; Kobiyama A; Kawataka M; Yamazaki M; Asano R; Hounoki H; Shinoda K; Tobe K
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):57-62. PubMed ID: 37341710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to rituximab in a refractory case of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus.
    Niaz FA; Aleem A
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):109-12. PubMed ID: 20061703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic lupus erythematosus and thrombotic thrombocytopenia purpura: a refractory case without lupus activity.
    Garcia Boyero R; Mas Esteve E; Mas Esteve M; Millá Perseguer MM; Marco Buades J; Beltran Fabregat J; Cañigral Ferrando G; Belmonte Serrano MA
    Reumatol Clin; 2013; 9(6):373-5. PubMed ID: 23473755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of autoimmune thrombocytopenic purpura with rituximab in a dialysis patient with systemic lupus erythematosus.
    Lee SY; Hsu PY; Juan KC; Chang H; Huang WH; Lai PC
    Int Immunopharmacol; 2010 May; 10(5):632-4. PubMed ID: 20172055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab or cyclosporin in refractory immune thrombocytopenia secondary to connective tissue diseases: a real-world observational retrospective study.
    Sun F; Chen J; Wu W; Geng S; Xu W; Sun S; Chen Z; Gu L; Wang X; Li T; Ye S
    Clin Rheumatol; 2020 Oct; 39(10):3099-3104. PubMed ID: 32418039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychloroquine alone for severe immune thrombocytopenic purpura associated with systemic lupus erythematosus.
    Blasco LM
    Lupus; 2013 Jun; 22(7):752-3. PubMed ID: 23698017
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and Safety of Rituximab in Systemic Lupus Erythematosus and Sjögren Syndrome Patients With Refractory Thrombocytopenia: A Retrospective Study of 21 Cases.
    Jiang B; Li T; Guo L; Shen H; Ye S; Chen S
    J Clin Rheumatol; 2015 Aug; 21(5):244-50. PubMed ID: 26203828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.